Source: Virtual Congress 2020 – Asthma inhalers: devices and adherence studies
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
D. Ramos Apolaya (Sevilla, Spain), M. Romero Falcón (Sevilla, Spain), J. Medina Gallardo (Sevilla, Spain), A. Gómez-Bastero Fernández (Sevilla, Spain), F. Alvarez Gutierrez (sevilla, Spain), J. Delgado Romero (sevilla, Spain), C. Campos Sien (sevilla, Spain), P. Rytilä (Spoo, Finland). Late Breaking Abstract - Dry Powder Inhaler Preference in asthma patients. Results of the DPI PREFER Study. 3173

Member's Comments

No comment yet.

Related content which might interest you: Late Breaking Abstract - Factors associated with health-status of COPD patients on Dry Powder Inhaler (DPI) maintenance therapy Source: Virtual Congress 2021 – Highlights for primary care in 2021 Year: 2021 Late Breaking Abstract - Lung deposition of two different ICS/LABA combinations with Dry Powder Inhaler (DPI) in asthmatic patients using Functional Respiratory Imaging (FRI). Source: International Congress 2019 – Imaging for prognostication and disease characterisation: 2019 update Year: 2019 Late Breaking Abstract - TriOptimize VIII – Improvement of Lung Function with Extrafine Single Inhaler Triple Therapy – Analysis of Response Patterns by Prior Treatment from a Real-World Study. Source: Virtual Congress 2020 – Pharmacological management of COPD Year: 2020 Cost Effectiveness Comparison of a Dry Powder Inhaler to a Metered Dose Inhaler plus Valved Holding Chamber based on a Functional Respiratory Imaging (FRI) Model Source: Virtual Congress 2021 – Difficult decisions on expected outcomes: availability of hospital resources and improvement of treatment adherence Year: 2021 Cost Effectiveness Comparison of a Dry Powder Inhaler to a Metered Dose Inhaler plus Valved Holding Chamber based on an In-Vitro Drug Delivery Model Source: Virtual Congress 2020 – Inhaler devices in COPD: technical advances, adherence studies and more Year: 2020 Late Breaking Abstract - Standard-of-Care Asthma Controller Regimen Reduction with Benralizumab Treatment: ANDHI In Practice Study Source: Virtual Congress 2021 – Severe asthma: evaluation using patient-reported outcome measures (PROMs) and biomarkers, comorbidities and treatments Year: 2021 Late Breaking Abstract - SUPRAnav: A Clinical Trial Evaluating the Efficacy and Safety of a New Invention Device Designed for Continuous Supraglottic Aspiration in Mechanically Ventilated Patients. Source: International Congress 2019 – ALERT: Abstracts Leading to Evolution in Respiratory Medicine Trials: Intensive care and infection Year: 2019 Late Breaking Abstract - Bronchial Rheoplasty For Treatment of Chronic Bronchitis: 6 Month Results from a Prospective Multi-Center Study Source: International Congress 2019 – ALERT: Abstracts Leading to Evolution in Respiratory Medicine Trials: COPD and cough Year: 2019 BREEZE: Open-label, Clinical Study to Evaluate the Safety and Tolerability of a Treprostinil Dry Powder Inhaler in Patients with Pulmonary Arterial Hypertension Currently Using Tyvaso Source: Virtual Congress 2021 – Therapy of pulmonary hypertension Year: 2021 Late Breaking Abstract - Blood Eosinophils as Predictor of Outcomes in hospitalized COPD Exacerbations: Results from a Prospective Study Source: International Congress 2019 – Eosinophils and FeNO in airway diseases Year: 2019 Late Breaking Abstract - Comparison of Portable Oxygen Concentrators using a COPD Patient Simulation Model Source: Virtual Congress 2021 – Lung function evaluation and assessment of airway diseases Year: 2021 Late Breaking Abstract - Bronchoscopic Thermal Vapor Ablation (BTVA) Outcomes at 12 months in Emphysema Patients with Severe Hyperinflation, a STEP-UP RCT Subgroup Analysis Source: International Congress 2017 – Late-breaking findings in asthma and COPD Year: 2017 Late Breaking Abstract - Patient Reported Outcomes (PRO) Correlate Better with Intra-Breath than with Whole-Breath FOT Parameters. Source: International Congress 2017 – Late-breaking findings in asthma and COPD Year: 2017 Late Breaking Abstract - WEAning From NonInvasive Ventilation – ‘WEANIV’ Study Source: Virtual Congress 2020 – ALERT: Ventilation and rehabilitation Year: 2020 Perception and Usage Among Indian Physicians of Long Acting Dual Bronchodilators in COPD: PATTERN Study Source: Virtual Congress 2020 – Pharmacological management of COPD Year: 2020 Safety and Feasibility of Metered CryoSpray (MCS) for Patients with Chronic Bronchitis in COPD: 9 Month Results. Source: International Congress 2019 – Bronchoscopic treatment of COPD: hot news Year: 2019 Late Breaking Abstract - Effects of a new Airway Clearance Technology versus manual physiotherapy in COPD Source: International Congress 2018 – Functional assessment of COPD Year: 2018 Late Breaking Abstract - Effectiveness of Fluticasone furoate/vilanterol (FF/VI) compared to usual care (UC) in patients with asthma: The Salford Lung Study (SLS) Source: International Congress 2017 – Late-breaking studies in asthma and COPD Year: 2017 Late Breaking Abstract - Real-World Characteristics of Patients Receiving Dupilumab in Routine Clinical Practice in a Multinational, Non-Interventional Study (ProVENT) Source: Virtual Congress 2021 – Airway pharmacology: translational and basic science Year: 2021 Late Breaking Abstract - Endobronchial Valves for Severe Emphysema – 12-month Results of the EMPROVE Trial Source: International Congress 2018 – Interventional pulmonology highlights in 2018: ELVR, TLD and BT Year: 2018